Treatment of factor VIII inhibitors with selective IgG immunoadsorption - A single center experience in 50 patients with acquired hemophilia

Transfusion Medicine and Hemotherapy

Volumn 33, Issue 2, 2006, Pages 160-164

  Zeitler, Heike ^a   Ulrich Merzenich, Gudrun ^a   Walger, Peter ^a   Vetter, Hans ^a   Oldenburg, Johannes ^a   Goldmann, Georg ^a   Brackmann, Hans Hermann ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Acquired hemophilia; FVIII immune tolerance; Immunoadsorption; Immunomodulation; MBMP protocol

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIBODY; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ADULT; AGED; ALOPECIA; ANOREXIA; ANTIBODY TITER; BLEEDING; CLINICAL PROTOCOL; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG POTENCY; FEMALE; FEVER; FOLLOW UP; HAIR LOSS; HEMOPHILIA; HUMAN; IMMUNOADSORPTION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; REMISSION; SEPSIS; THROMBOCYTOPENIA;

EID: 33645664290     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091113     Document Type: Conference Paper

References (21)

1. Kessler CM: New perspectives in hemophilia treatment. Hemotology 2005;1:429-438.
2. Freiburghaus C: Extracorporeal Immunoadsorption. Lund, BTJ Tryck AB, 1998, pp 1-35.
3. Cohen AJ, Kessler CM: Acquired inhibitors. Baillières Clin Haematol 1996;9:331-354.
4. Delgado J, Yuste V, Navarro F, Villar A: Acquired haemophiHa: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003;121:21-35.
5. Schwartz R, Gabriel D, Aledort L, Green D, Kessler C: Prospective study of treatment of acquired (autoimmune) Factor VIII inhibitors with high dose intravenous gammaglobulin. Blood 1995;86:797-804.
6. Grodreuil S, Navarro R. Qittet L: Acquired haemophilia in the elderly is a severe disease: report of five new cases. Haemophilia 2001;4:428-432.
7. Green D, Lechner K: A Survey of 215 nonhaemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981;4:200-203.
8. Shastri KA, Ho C, Logue G: An acquired factor V inhibitor: clinical and laboratory features. J Med 1999;30:357-366.
9. Largo R, Sigg P, Feiten A, Straub PW: Acquired factor IX inhibitor in a non-haemophilic patient with autoimmune disease. Br J Haematol 1974;26:129-140.
10. Zeitler H, Ulrich-Merzenich G, Hess L. et al: Treatment of acquired hemophilia by the Bonn-Malmö Protocol: documentation of an in vivo imunomodulating concept. Blood 2005;105:2287-2293.
11. Brackmann HH, Oldenburg J, Schwaab R: Immune tolerance for the treatment of factor VIII inhibitor - twenty years 'Bonn protocol'. Vox Sang 1996;70:30-35.
12. Giles AR, Verbruggen B, Rivard GE, Teitel J, Walker I: A detailed comparison of the performance of the standard versus Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the Haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis. Thromb Haemost 1998;79:872-875.
13. Nilson IM. Freiburghaus C: Apheresis. Adv Exp Med Biol 1995;386:175-184.
14. Jansen M, Schmaldienst S, Banyal S, Quehenberger P, Pabinger I, Derfler K: Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb). Br J Haematol 2001;112:91-97.
15. Fischer KG, Deschler B, Lübbert M: Acquired high-titre factor VIII inhibitor: fatal bleeding dë spite multimodal treatment including rituximab preceded by multiple plasmapheresis. Blood 2003; 11:3753-3754.
16. Abdallah A, Coghlan DW, Duncan EM, Chunilal SD, Lloyd JV: Rituximab induced long term remission in patients with refractory acquired hemophilia. J Thromb Haemost 2005;3:2589-2590.
17. Stasi R, Brunetti M, Stipa E, Amadori S: Selective B cell-depletion with rituximab for the treatment of patients with acquired hemophilia. Blood 2004; 103:4424-4428.
18. Huang,YW, Saidi P Philipp C: Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases. Haemophilia 2004;10:713-721.
19. Hauser I, Schneider B, Lechner K: Post-partum factor VIII inhibitors. A review of literature with special reference of the value of steroids and immunosuppressive treatment. Thromb Haemost 1995;73:1-5.
20. Lian EC, Villar MJ, Noy LI, Ruiz-Dayao Z: Acquired factor VIII inhibitor treated with cyclophosphamide, vincristine and prednisone. Am J Hematol 2002;69:294-295.
21. Von Depka M: Erworbene Hämophilie infolge Antikörperbildung gegen Faktor VIII. Hämostaseologie 2003;23:28-35.